Skip to content

Digoxin

Digoxin, Lanoxicaps, Lanoxin, Lanoxin Pediatric (digoxin) is a small molecule pharmaceutical. Digoxin was first approved as Digoxin on 1982-01-01. It is used to treat anxiety disorders, atrial fibrillation, atrial flutter, cardiogenic shock, and heart failure amongst others in the USA. The pharmaceutical is active against sodium/potassium-transporting ATPase subunit alpha-1.
Trade Name Digoxin, Lanoxicaps, Lanoxin, Lanoxin Pediatric
Common Name Digoxin
Indication anxiety disorders, atrial fibrillation, atrial flutter, cardiogenic shock, heart failure, low cardiac output, supraventricular tachycardia
Drug Class Fluoroquinolone derivatives, nonantibacterial indications (e.g., antineoplastic antibiotics)
Digoxin
Get full access now